Sources of Funding
Novartis Pharma AG initiated and provided funding for this study and provided medical writing and editorial support in the development of the manuscript. The funder was also involved in study design and data collection, analysis, and interpretation, as well as review and feedback on the manuscript. The authors, who include both academic investigators and employees of the funder, had full editorial control of the manuscript and provided final approval of all content. All authors had access to the data and contributed to the review of and revisions to manuscript drafts. All authors vouch for the accuracy and completeness of the data and for the fidelity of the trial to the protocol.